Intravenous Administration of Allogenic Cell-Derived Microvesicles of Healthy Origins Defends Against Atherosclerotic Cardiovascular Disease Development by a Direct Action on Endothelial Progenitor Cells
出版年份 2020 全文链接
标题
Intravenous Administration of Allogenic Cell-Derived Microvesicles of Healthy Origins Defends Against Atherosclerotic Cardiovascular Disease Development by a Direct Action on Endothelial Progenitor Cells
作者
关键词
-
出版物
Cells
Volume 9, Issue 2, Pages 423
出版商
MDPI AG
发表日期
2020-02-25
DOI
10.3390/cells9020423
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Platelets of Healthy Origins Promote Functional Improvement of Atherosclerotic Endothelial Progenitor Cells
- (2019) Nicoleta Alexandru et al. Frontiers in Pharmacology
- Extracellular vesicles in atherosclerosis
- (2019) WenYi Deng et al. CLINICA CHIMICA ACTA
- Circulating ectosomes: Determination of angiogenic microRNAs in type 2 diabetes
- (2018) Ewa Ł. Stępień et al. Theranostics
- Microvesicles as Emerging Biomarkers and Therapeutic Targets in Cardiometabolic Diseases
- (2018) Yan Chen et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- Vascular complications in diabetes: Microparticles and microparticle associated microRNAs as active players
- (2016) Nicoleta Alexandru et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Effects of transplanted circulating endothelial progenitor cells and platelet microparticles in atherosclerosis development
- (2016) Adriana Georgescu et al. BIOLOGY OF THE CELL
- Role of MicroRNA in Endothelial Dysfunction and Hypertension
- (2016) Miruna Nemecz et al. CURRENT HYPERTENSION REPORTS
- Microvesicles and exosomes: new players in metabolic and cardiovascular disease
- (2016) Charlotte Lawson et al. JOURNAL OF ENDOCRINOLOGY
- Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts
- (2016) S Baroni et al. Cell Death & Disease
- Microparticles: From Biogenesis to Biomarkers and Diagnostic Tools in Cardiovascular Disease
- (2016) Nicoleta Alexandru et al. Current Stem Cell Research & Therapy
- Perspective: The RNA exosome, cytokine gene regulation and links to autoimmunity
- (2015) Juliana Blin et al. CYTOKINE
- Lack of TAFI increases brain damage and microparticle generation after thrombolytic therapy in ischemic stroke
- (2015) J. Orbe et al. THROMBOSIS RESEARCH
- EPC-Derived Microvesicles Protect Cardiomyocytes from Ang II-Induced Hypertrophy and Apoptosis
- (2014) Shenhong Gu et al. PLoS One
- Irbesartan administration therapeutically influences circulating endothelial progenitor cell and microparticle mobilization by involvement of pro-inflammatory cytokines
- (2013) Adriana Georgescu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Circulating Endothelial Progenitor Cell and Platelet Microparticle Impact on Platelet Activation in Hypertension Associated with Hypercholesterolemia
- (2013) Nicoleta Alexandru et al. PLoS One
- Microparticles: major transport vehicles for distinct microRNAs in circulation
- (2012) P. Diehl et al. CARDIOVASCULAR RESEARCH
- Leukocyte- and endothelial-derived microparticles: a circulating source for fibrinolysis
- (2012) R. Lacroix et al. HAEMATOLOGICA
- Circulating microparticles and endothelial progenitor cells in atherosclerosis: pharmacological effects of irbesartan
- (2012) A. GEORGESCU et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Action of polystyrene nanoparticles of different sizes on lysosomal function and integrity
- (2012) Eleonore Fröhlich et al. Particle and Fibre Toxicology
- microRNA expression signatures and parallels between monocyte subsets and atherosclerotic plaque in humans
- (2012) Bernd Denecke et al. THROMBOSIS AND HAEMOSTASIS
- Circulating MicroRNAs
- (2011) Stephan Fichtlscherer et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study
- (2011) Emma Raitoharju et al. ATHEROSCLEROSIS
- Biogenesis and Regulation of Cardiovascular MicroRNAs
- (2011) Johann Bauersachs et al. CIRCULATION RESEARCH
- MicroRNA-200b Regulates Vascular Endothelial Growth Factor-Mediated Alterations in Diabetic Retinopathy
- (2011) K. McArthur et al. DIABETES
- Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation?
- (2011) Morgane Baron et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- A Unique MicroRNA Signature Associated With Plaque Instability in Humans
- (2011) Francesco Cipollone et al. STROKE
- MicroRNAs and vascular (dys)function
- (2011) Dorothee Hartmann et al. VASCULAR PHARMACOLOGY
- Microparticles
- (2010) Sebastian F. Mause et al. CIRCULATION RESEARCH
- Circulating MicroRNAs as Biomarkers and Potential Paracrine Mediators of Cardiovascular Disease
- (2010) Shashi K. Gupta et al. Circulation-Cardiovascular Genetics
- Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis
- (2010) E. SHANTSILA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Intracellular Delivery Strategies for MicroRNAs and Potential Therapies for Human Cardiovascular Diseases
- (2010) M. A. Shi et al. Science Signaling
- Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures
- (2009) M. Prokopi et al. BLOOD
- Microparticles From Ischemic Muscle Promotes Postnatal Vasculogenesis
- (2009) Aurelie S. Leroyer et al. CIRCULATION
- Rethinking the reasons to treat atrial fibrillation? The role of dronedarone in reducing cardiovascular hospitalizations
- (2009) R. H. Falk et al. EUROPEAN HEART JOURNAL
- Chronic venous insufficiency is associated with elevated level of circulating microparticles
- (2009) A. GEORGESCU et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Delivery of MicroRNA-126 by Apoptotic Bodies Induces CXCL12-Dependent Vascular Protection
- (2009) A. Zernecke et al. Science Signaling
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started